Skip to main content

WTW at the LSX World Congress 2022

About the LSX World Congress

For the last seven years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal making.

LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly healthcare giants, and everyone in between.

It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

Who is attending?

The biotech, healthtech and medtech industry’s c-suite will be joined by the sector’s most active investors, pharma and health technology business development and licensing (BD&L) teams, research and development (R&D) leaders, key opinion leaders (KOL) and top tier service companies who are driving the sector forward.

In an industry as dynamic as this, LSX World Congress brings together the people who are developing technologies, solutions and new business models to tackle the biggest healthcare challenges in the industry today, and helps answer the question; what’s next and how do we get there?

WTW is pleased to be sponsoring the LSX World Congress in 2022, helping to provide an insurance and risk management perspective.

London Congress

WTW is delighted to be leading the biotech leader session on:

Managing Risk In The New World – Security, Data, Resilience In The Biopharma Supply Chain

Join us on Wednesday 11 May 2022, 11:00am – 12:00pm UK time

The last 24 months have been quite historic for organisations within the life sciences and healthcare industries. In addition to the obvious global COVID-19 response, businesses have continued to grow and evolve in cyber terms.

Whether it be innovations in cyber-enabled treatments or therapies, or making the best use of technology to support efficient delivery of organisational objectives and business strategies, one thing is clear – the industry is at the very forefront of the cyber operating environment.

With this level of innovation, the heightened degree of interaction within the cyber space, and in considering the ‘data heavy’ and highly regulated nature of the industry, all against a backdrop of growing and emerging cyber threats, it is crucial that life science sand healthcare organisations of all types view cyber risk as being amongst, if not the, biggest risks to their businesses.

  • What does the cyber threat landscape look like for this industry?
  • Have cyber security practices kept pace with innovation and the implementation of new technologies?
  • Is the convergence of the physical and virtual domains fully understood by this industry, and what are the risks in this space?
  • How can organisations better protect themselves in the now, and what or where should they focus their efforts in looking ahead?

Andrew Hill - Product Innovation Lead, WTW
Simon Basham - GB Cyber Head of Broking, WTW
David Crome - Managing Director Compliance UK, ProPharma Group

Get in touch with our experts below to arrange a meeting with WTW at the London Congress

North American Practice Leader – Life Sciences

John leads a Life Sciences network of more than 150 Associates in the USA and 200 globally. John joined WTW in August, 2007, serving in a variety of leadership positions prior to his current role. John has over 35 years of experience with more than 20 years of focus on the life sciences industry. In his role as Practice Leader he ensures that each of our clients benefits from our collective global experience, expertise, creativity and commitment to excellence in proactively identifying their needs and developing solutions that suit their company.

GB Practice Leader – Life Sciences

Neil serves the GB life science community by drawing on WTW's sector knowledge and resource in order to create personalised risk and insurance programmes. He maintains a good understanding of the challenges and changes occurring both within the industry sub-sectors and specialist insurers. Throughout Neil’s 40+ year insurance career he has worked with Boards, Operations and Investors to create value. His experience helps life science businesses understand the risk environment, be better prepared for when events happen and recover earlier. He is Fellow of the Institute of Risk Management and has an MBA from Aston University.

Edward Hunter
Life Sciences Broking Leader

Edward joined WTW in October 2005. His focus is on all aspects of brokerage services and placements within the London and international markets for a variety of casualty programs. Within that role Edward also leads the Global Markets P&C Hub's Life Science Practice. He has gained an excellent knowledge of the London marketplace and developed relationships with UK, US, European and Bermudan underwriters. Edward has more than 16 years of experience in marketing, broking and placement in respects to US, UK and international liability programs.

Scott McMahon
Client Advocate, Life Sciences Practice

Scott McMahon leads the Life Sciences Industry for the Midwest US Region of WTW. Scott, a technical expert in his field, understands his clients’ needs, challenges and risks. Armed with this knowledge and his consultative approach, Scott works with his clients to make the best risk and financial decisions possible, now and in the future. Scott began his insurance career with a leading international insurance brokerage where he led the Midwest Healthcare and Life Science practice. Prior to joining the insurance industry, he worked for a variety of pharmaceutical, biotechnology and medical device companies, building a foundation of industry expertise that allows him to bring tremendous value to his clients in these spaces.

Jonathan Brisker
New Industry Management

Jonathan joined WTW in 2021 as a Director. Jonathan has over 20 years’ experience in the insurance industry, working in London and New York. The last 15 years have been focused on working with Private Equity and Infrastructure Funds ranging from pre-acquisition to financial close. Jonathan has also supported Financial Investors in creating portfolio solutions across their various insurance programmes for their assets.

LSX is committed to keeping everyone attending the Congress as safe as possible. Learn more about their safety protocols here.

Nordic Congress

More info to follow soon!


WTW offers insurance-related services through its appropriately licensed and authorised companies in each country in which WTW operates. For further authorisation and regulatory details about our WTW legal entities, operating in your country, please refer to our WTW website.

It is a regulatory requirement for us to consider our local licensing requirements.

Contact Us